Bone mass and the risk of breast cancer among postmenopausal women

New England Journal of Medicine

Volumn 336, Issue 9, 1997, Pages 611-617

  Zhang, Yuqing ^a,g   Kiel, Douglas P ^b   Kreger, Bernard E ^a   Cupples, L Adrienne ^c   Ellison, R Curtis ^a   Dorgan, Joanne F ^d   Schatzkin, Arthur ^d   Levy, Daniel ^a,e,f   Felson, David T ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON UNIVERSITY   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e Framingham Study   (United States)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^g BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BONE MASS; BONE MINERAL; BREAST CANCER; CANCER RISK; CIGARETTE SMOKING; EDUCATION; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; HAND RADIOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; METACARPAL BONE; PARITY; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; BONE DENSITY; BREAST NEOPLASMS; ESTROGENS; FEMALE; HUMANS; INCIDENCE; METACARPUS; MIDDLE AGED; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 0031049425     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199702273360903     Document Type: Article

References (58)

1. de Waard F, Trichopoulos D. A unifying concept of the aetiology of breast cancer. Int J Cancer 1988;41:666-9.
2. Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev 1993;15:48-65.
3. Brinton LA, Schairer C. Estrogen replacement therapy and breast cancer risk. Epidemiol Rev 1993;15:66-79.
4. Plymate SR, Moore DE, Cheng CY, Bardin CW, Southworth MB, Levinski MJ. Sex hormone-binding globulin changes during the menstrual cycle. J Clin Endocrinol Metab 1985;61:993-6.
5. Anttila L, Koskinen P, Irjala K, Kaihola HL. Reference intervals for serum sex steroids and gonadotropins in regularly menstruating women. Acta Obstet Gynecol Scand 1991;70:475-81.
6. McIntosh JEA, Matthews CH, Crocker JM, Broom TJ, Cox LW. Predicting the luteinizing hormone surge: relationship between the duration of the follicular and luteal phases and the length of the human menstrual cycle. Fertil Steril 1980;34:125-30.
7. Leonard PJ. Routine clinical assays of hormones and their metabolites. In: Loraine JA, Bell ET, eds. Hormone assays and their clinical application. 4th ed. Edinburgh, Scotland: Churchill Livingstone, 1976:657-77.
8. Harris RB, Laws A, Reddy VM, King A, Haskell WL. Are women using postmenopausal estrogens? A community survey. Am J Public Health 1990;80:1266-8.
9. Egeland GM, Matthews KA, Kuller LH, Kelsey SF. Characteristics of noncontraceptive hormone users. Prev Med 1988;17:403-11.
10. Browner WS, Pressman AR, Nevitt MC, Cauley JA, Cummings SR. Association between low bone density and stroke in elderly women: the Study of Osteoporotic Fractures. Stroke 1993;24:940-6.
11. Browner WS, Seeley DG, Vogt TM, Cummings SR. Non-trauma mortality in elderly women with low bone mineral density: Study of Osteoporotic Fractures Research Group. Lancet 1991;338:355-8.
12. Olsson H, Hagglund G. Reduced cancer morbidity and mortality in a prospective cohort of women with distal forearm fractures. Am J Epidemiol 1992;136:422-7.
13. Persson I, Adami HO, McLaughlin JK, Naessen T, Fraumeni JF Jr. Reduced risk of breast and endometrial cancer among women with hip fractures (Sweden). Cancer Causes Control 1994;5:523-8.
14. Cauley JA, Lucas FL, Kuller LH, Vogt MT, Browner WS, Cummings SR. Bone mineral density and risk of breast cancer in older women: the Study of Osteoporotic Fractures. JAMA 1996;276:1404-8.
15. Horsman A, Simpson M. The measurement of sequential changes in cortical bone geometry. Br J Radiol 1975;48:471-6.
16. Garn SM, Rohmann CG, Wagner B, Ascoli W. Continuing bone growth throughout life: a general phenomenon. Am J Phys Anthropol 1967;26:313-7.
17. Garn SM, Rohmann CG, Nolan P Jr. The developmental nature of bone changes during aging. In: Birren JE, ed. Relations of development and aging. Springfield, Ill.: Charles C Thomas, 1964:41-61.
18. Kreger BE, Splansky GL, Schatzkin AS. The cancer experience in the Framingham Heart Study cohort. Cancer 1991;67:1-6.
19. ICD-O: international classification of diseases for oncology. Geneva: World Health Organization, 1976.
20. Kannel WB, Sorlie P. Some health benefits of physical activity: the Framingham Study. Arch Intern Med 1979;139:857-61.
21. Lee ET. Statistical methods for survival data analysis. Belmont, Calif.: Lifetime Learning, 1980.
22. Kelsey JL. Breast cancer epidemiology: summary and future directions. Epidemiol Rev 1993;15:256-63.
23. Bulbrook RD, Moore JW, Clark GM, Wang DY, Millis RR, Hayward JL. Relation between risk of breast cancer and biological availability of estradiol in the blood: prospective study in Guernsey. Ann N Y Acad Sci 1986;464:378-88.
24. Wysowski DK, Comstock GW, Helsing KJ, Lau HL. Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemiol 1987;125:791-9.
25. Garland CF, Friedlander NJ, Barrett-Connor E, Khaw KT. Sex hormones and postmenopausal breast cancer: a prospective study in an adult community. Am J Epidemiol 1992;135:1220-30.
26. Helzlsouer KJ, Alberg AJ, Bush TL, Longcope C, Gordon GB, Comstock GW. A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev 1994;18:79-85.
27. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 1995;87:190-7.
28. Berrino F, Muti P, Micheli A, et al. Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst 1996;88:291-6.
29. Dorgan JF, Longcope C, Stephenson HE Jr, et al. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol Biomarkers Prev 1996;5:533-9.
30. Armstrong BK. Oestrogen therapy after the menopause - boon or bane? Med J Aust 1988;148:213-4.
31. Dupont WD, Page DL. Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med 1991;151:67-72.
32. Steinberg KK, Thacker SB, Smith SJ, et al. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 1991; 265:1985-90. [Erratum, JAMA 1991;266:1362.]
33. Sillero-Arenas M, Delgado-Rodriguez M, Rodigues-Canteras R, Bueno-Cavanillas A, Galvez-Vargas R. Menopausal hormone replacement therapy and breast cancer: a meta-analysis. Obstet Gynecol 1992;79:286-94.
34. Colditz GA, Egan KM, Stampfer MJ. Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies. Am J Obstet Gynecol 1993;168:1473-80.
35. Steinberg KK, Smith SJ, Thacker SB, Stroup DF. Breast cancer risk and duration of estrogen use: the role of study design in meta-analysis. Epidemiology 1994;5:415-21.
36. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589-93.
37. Bonjour JP, Theintz G, Buchs B, Slosman D, Clavien H, Rizzoli R. Variation in spinal and femoral bone mass gain, energy and calcium intake during adolescence. Osteoporos Int 1993;3:Suppl 1:67-8.
38. Bonjour JP, Theintz G, Buchs B, Slosman D, Rizzoli R. Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab 1991;73:555-63.
39. Meema HE, Meema S. Involutional (physiologic) bone loss in women and the feasibility of preventing structural failure. J Am Geriatr Soc 1974; 22:443-52.
40. Falch JA, Sandvik L. Perimenopausal appendicular bone loss: a 10-year prospective study. Bone 1990;11:425-8.
41. van Hemert AM, Birkenhager JC, De Jong FH, Vandenbroucke JP, Valkenburg HA. Sex hormone binding globulin in postmenopausal wornen: a predictor of osteoporosis superior to endogenous oestrogens. Clin Endocrinol (Oxf) 1989;31:499-509.
42. Cauley JA, Gutai JP, Kuller LH, et al. Endogenous estrogen levels and calcium intakes in postmenopausal women: relationships with cortical bone measures. JAMA 1988;260:3150-5. [Erratum, JAMA 1989;261: 1154.]
43. Cauley JA, Gutai JP, Sandler RB, LaPorte RE, Kuller LH, Sashin D. The relationship of endogenous estrogen to bone density and bone area in normal postmenopausal women. Am J Epidemiol 1986;124:752-61.
44. Cauley JA, Gutai JP, Kuller LH, Scott J, Nevitt MC. Black-white differences in serum sex hormones and bone mineral density. Am J Epidemiol 1994;139:1035-46.
45. Murphy S, Khaw KT, Sneyd MJ, Compston JE. Endogenous sex hormones and bone mineral density among community-based postmenopausal women. Postgrad Med J 1992;68:908-13.
46. Mazzuoli G, Minisola S, Bianchi G, et al. The effects of oophorectomy on skeletal metabolism. J Steroid Biochem Mol Biol 1990;37:457-9.
47. Weiss NS, Ure CL, Ballard JH, Williams AR, Daling JR. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 1980;303:1195-8.
48. Paganini-Hill A, Ross RK, Gerkins VR, Henderson BE, Arthur M, Mack TM. Menopausal estrogen therapy and hip fractures. Ann Intern Med 1981;95:28-31.
49. Ettinger B, Genant HK, Cann CE. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 1985;102:319-24.
50. Felson DT, Zhang Y, Hannan MT, Kiel DP, Wilson PWF, Anderson JJ. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 1993;329:1141-6.
51. Kiel DP, Felson DT, Anderson JJ, Wilson PWF, Moskowitz MA. Hip fracture and the use of estrogens in postmenopausal women: the Framingham Study. N Engl J Med 1987;317:1169-74.
52. Buchanan JR, Myers C, Lloyd T, Levenberger P, Demers LM. Determinants of peak trabecular bone density in women: the role of androgens, estrogen, and exercise. J Bone Miner Res 1988;3:673-80.
53. Ziegler R, Scheidt-Nave C, Scharla S. Pathophysiology of osteoporosis: unresolved problems and new insights. J Nutr 1995;125:Suppl:2033s-2037s.
54. van Hemert AM, Vandenbroucke JP, Hofman A, Valkenburg HA. Metacarpal bone loss in middle-aged women: "horse racing" in a 9-year population based follow-up study. J Clin Epidemiol 1990;43:579-88.
55. Genant HK, Cann CE, Ettinger B, Gordan GS. Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med 1982;97:699-705.
56. Exton-Smith AN, Millard PH, Payne PR, Wheeler EF. Method for measuring quantity of bone. Lancet 1969;2:1153-4.
57. Aitken JM, Smith CB, Horton PW, Clark DL, Boyd JF, Smith DA. The interrelationships between bone mineral at different skeletal sites in male and female cadavera. J Bone Joint Surg Br 1974;56:370-5.
58. Madigan MP, Ziegler RG, Benichou J, Byrne C, Hoover RN. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 1995;87:1681-5.